May 2020 FDA Recall Drug by Triova Pharmaceuticals Llc
D-1284-2020 - Failed impurities/ degradation specifications
This Class II drug recall was voluntarily initiated by Triova Pharmaceuticals Llc on May 15, 2020 for the product Drug. The FDA reported the reason for recall as failed impurities/ degradation specifications. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1284-2020
Failed impurities/ degradation specifications: Out of specification for organic impurities.
05-15-2020
06-10-2020
210 grams
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
TRIOVA PHARMACEUTICALS LLC
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
U.S.A. Nationwide
06-01-2023
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Estriol USP Micronized 5 G, Rx only, Triova 115 W 3rd Street Suite 720 Tulsa, OK 74103, NDC 71092-9977-02
Batch or Lot Expiration Information
Lot# :17010401181119190927, EXP 12/2020, 1701040118111919092725200122, EXP.12/2020